Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia
• Patients willing to provide written informed consent
Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Contact Information
Primary
Michael Stachowitz
Stachowitz.Michael@mayo.edu
507-284-4862
Time Frame
Start Date: 2018-08-01
Estimated Completion Date: 2028-01
Participants
Target number of participants: 635
Treatments
ILD
250 patients (male and females \>18 years of age) with the diagnosis of fibrotic DILD (IPF (n=100), fibrotic NSIP (n=50), chronic hypersensitivity pneumonia (n=20), sarcoidosis(n=50), progressive rheumatoid lung disease (n=10) and scleroderma lung disease (n=20), 10 patients with other fibrosing disease (fibrosing mediastinitis), and 50 patients with lymphangioleiomyomatosis.
Healthy
100 healthy participants as a control group.
Pneumonia
25 patients with pneumonia as a control group.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic